SUBMIT YOUR MANUSCRIPTS IN TWO STEPS
Please read [**Our APC WAIVERS terms**] before you submit your papers
Submission guide
Pathology, Immunology, and Cancer research papers can be submitted to the Special Journal of Pathology, Immunology, and Cancer for attention. To submit a manuscript to the, we recommend the use of strobes guidelines or checklist as adapted from the strobe guideline for observational studies (STROBES) as indicated here If you can say yes to all the questions, then you are ready to submit your manuscript for consideration. You are advised to use the form above to submit your manuscript for consideration and publication in the Special Journal of Pathology, Immunology, and Cancer. We need only word format so it can be easy to put in the reviewer’s comments using track changes.
For submission of a non-observational study manuscript, you are advised to follow the authors’ information to comply with our writing format so as to pass editorial screening before papers are sent for external peer review! If the editorial office is not satisfied, your manuscript may be returned to you for attention within 48hrs! Thank you for choosing to publish with us.
Adapted from the
strobe guideline for observational studies (STROBES)
| S/N | Section | Question | answer |
| 1 | Title and abstract: | Study’s design in the title/abstract indicated | |
| 2 | Background/Rationale: | Informative/balanced summary of methods and key results provided in the abstract |
|
| 3. | Objective: | Scientific background and rationale for reported investigation clearly explained |
|
| 4. | Study design: | Key elements of study design presented | |
| 5. | Setting: | The setting, locations, dates, periods of recruitment, exposure, follow-up, and data collection clearly described |
|
| 6. | Participants: | Study type, Eligibility/matching criteria, participants selection, case ascertainment, control and follow up methods/source, number of exposed, unexposed, and controls per case |
|
| 7. | Variables: | All outcomes, exposures, predictors, potential confounders, and effect modifiers; diagnostic criteria, clearly defined |
|
| 8. | Data source/measurement: | Sources of data, methods of assessment (measurement); describe comparability of assessment method(s) given in detail |
|
| 9 | Bias: | Efforts to address likely sources of bias defined | |
| 10. | Study size: | How the study size was derived clearly outlined | |
| 11. | Quantitative variables | How quantitative variables were analyzed include which groupings were chosen and why |
|
| 12. | Statistical methods: | All statistical methods, including those used to: control for confounding, examine subgroups and interactions, address missing data, loss to follow-up, matching of cases and controls, analyze sampling strategy and sensitivity explained |
|
| 13 | Participants: | Numbers of individuals potentially, examined or confirmed eligible at each stage of the study and those included in the study or completing follow-up, and reasons for nonparticipation are clearly defined, Consider use of a flow diagram |
|
| 14. | Descriptive data: | Characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders, number of participants with missing data for each variable of interest, summarize follow-up time (e.g., average and total amount) clearly defined |
|
| 15. | Outcome data: | Numbers of outcome events or summary measures over time, numbers in each exposure category, or summary measures of exposure and numbers of outcome events or summary measures, outlined |
|
| 16. | Main results: | Have you given unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence interval); make clear which confounders were adjusted for and why they were included, report category boundaries when continuous variables were categorized. |
|
| 17 | Other analysis: | Subgroups, interactions, and sensitivities reported | |
| 18. | Key results: | Key results in relation to study objectives reported | |
| 19 | Limitation: | limitations of the study, taking into account sources of potential bias or imprecision; discuss both direction and magnitude of any potential bias |
|
| 20. | Interpretation: | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence |
|
| 21 | Generalizability: | Discuss the generalizability (external validity) of the study results | |
| 22. | Funding: | the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based Funding |
Submit with the form above
If you have answered yes to all the questions indicated in the above checklist you are now ready to submit your manuscript. Just fill the forms and attach the file of not more than 5mb to submit. Accepted format include word document only
